JPWO2020243706A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020243706A5
JPWO2020243706A5 JP2021570851A JP2021570851A JPWO2020243706A5 JP WO2020243706 A5 JPWO2020243706 A5 JP WO2020243706A5 JP 2021570851 A JP2021570851 A JP 2021570851A JP 2021570851 A JP2021570851 A JP 2021570851A JP WO2020243706 A5 JPWO2020243706 A5 JP WO2020243706A5
Authority
JP
Japan
Prior art keywords
virus
recombinant
replication
host cell
icp27
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570851A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534119A (ja
JP2022534119A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/035558 external-priority patent/WO2020243706A1/en
Publication of JP2022534119A publication Critical patent/JP2022534119A/ja
Publication of JP2022534119A5 publication Critical patent/JP2022534119A5/ja
Publication of JPWO2020243706A5 publication Critical patent/JPWO2020243706A5/ja
Pending legal-status Critical Current

Links

JP2021570851A 2019-05-30 2020-06-01 組換えヘルペスウイルスベクター Pending JP2022534119A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962854637P 2019-05-30 2019-05-30
US62/854,637 2019-05-30
US201962873094P 2019-07-11 2019-07-11
US62/873,094 2019-07-11
PCT/US2020/035558 WO2020243706A1 (en) 2019-05-30 2020-06-01 Recombinant herpesvirales vector

Publications (3)

Publication Number Publication Date
JP2022534119A JP2022534119A (ja) 2022-07-27
JP2022534119A5 JP2022534119A5 (https=) 2023-06-09
JPWO2020243706A5 true JPWO2020243706A5 (https=) 2023-06-09

Family

ID=71787155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570851A Pending JP2022534119A (ja) 2019-05-30 2020-06-01 組換えヘルペスウイルスベクター

Country Status (10)

Country Link
US (1) US20220307052A1 (https=)
EP (1) EP3976806A1 (https=)
JP (1) JP2022534119A (https=)
KR (1) KR20220016150A (https=)
CN (1) CN114207120A (https=)
AU (1) AU2020284255A1 (https=)
CA (1) CA3142194A1 (https=)
IL (1) IL288419A (https=)
SG (1) SG11202113052YA (https=)
WO (1) WO2020243706A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114787179A (zh) * 2019-10-10 2022-07-22 坚固生物科技公司 经修饰的aav衣壳及其用途
EP3950948A1 (en) * 2020-08-07 2022-02-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Platform vector for modular and simplified insertion of transgenes into alphaherpesvirinae
WO2022067038A1 (en) * 2020-09-25 2022-03-31 President And Fellows Of Harvard College Immunotherapeutic virus for the treatment of cancer
US20240191251A1 (en) * 2021-04-05 2024-06-13 Solid Biosciences Inc. Recombinant herpesvirales vector
AU2022373653A1 (en) 2021-10-18 2024-05-02 Regeneron Pharmaceuticals, Inc. Eukaryotic cells comprising adenovirus-associated virus polynucleotides
CN114703327B (zh) * 2022-03-29 2024-11-26 广西壮族自治区兽医研究所 检测鸡传染性喉气管炎病毒的组合物及其应用
CN115927473B (zh) * 2022-07-15 2024-06-18 上海本导基因技术有限公司 一种用于单纯疱疹病毒感染性疾病的基因治疗药物
CN120435565A (zh) * 2022-12-01 2025-08-05 免疫医疗有限责任公司 腺相关病毒生产平台
CN116286924A (zh) * 2023-01-06 2023-06-23 齐鲁动物保健品有限公司 一种猫疱疹病毒ⅰ型感染性克隆质粒及其构建

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9700411D0 (en) * 1997-01-10 1997-02-26 Univ London Eukaryotic gene expression cassette and uses thereof
US20040063094A1 (en) * 1998-05-20 2004-04-01 Biovex Limited Mutant herpes simplex viruses and uses thereof
ATE437944T1 (de) 2000-04-28 2009-08-15 Asklepios Biopharmaceutical In Für das dystrophin-minigen kodierende dna- sequenzen und verfahren zu deren verwendung
ATE400656T1 (de) 2000-10-06 2008-07-15 Univ Michigan Mini-dystrophin nukleinsäure- und peptidsequenzen
GB0208390D0 (en) * 2002-04-11 2002-05-22 Univ London Adeno-associated virus producer system
CN1856576B (zh) 2003-09-30 2011-05-04 宾夕法尼亚州立大学托管会 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
JP5575486B2 (ja) 2007-01-18 2014-08-20 ユニヴァーシティ オブ ミズーリー−コロンビア 筋鞘にｎＮＯＳを回復させる合成ミニ／ミクロジストロフィン遺伝子
EP2960336A1 (en) 2014-06-27 2015-12-30 Genethon Efficient systemic treatment of dystrophic muscle pathologies
IL286316B2 (en) 2015-01-16 2023-03-01 Univ Washington New micro-dystrophins and related method of use
MX2019011046A (es) * 2017-03-17 2019-10-17 Res Inst Nationwide Childrens Hospital Administracion de vectores del virus adenoasociado de microdistrofina especifica del musculo para tratar la distrofia muscular.

Similar Documents

Publication Publication Date Title
US20220307052A1 (en) Recombinant herpesvirales vector
JP6837094B2 (ja) 培養物中のウイルス収量を増加させるためのｉＮＯＳ阻害剤の使用
CA3023592A1 (en) Adeno-associated virus variant capsids and methods of use thereof
EP3132051B1 (en) Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (rpgr)
US20110117058A1 (en) Method of treating genetic disorders
JPWO2020243706A5 (https=)
CN116782886A (zh) 密码子优化的rpgrorf15基因及其用途
KR20240025645A (ko) 아데노-연관된 바이러스 패키징 시스템
US20240191251A1 (en) Recombinant herpesvirales vector
Fraefell et al. Herpes simplex virus type 1-based amplicon vector systems
AU760308B2 (en) Latency-active regulatory sequences of herpesviruses and latency-inactive herpesviruses for gene transfer
Prieto et al. Development of new expression vector based on pseudorabies virus amplicons: application to human insulin expression
US20250340903A1 (en) Modified Herpes Simplex Virus Type 1
HK40100824A (zh) 密码子优化的rpgrorf15基因及其用途
JPWO2019161365A5 (https=)